GSK Defends Cold Vaccine Patents In Pfizer Challenge
GlaxoSmithKline has fired back at Pfizer's bid to invalidate three of its patents for common cold vaccines, claiming a London court should bar the U.S. pharma giant from infringing its IP....To view the full article, register now.
Already a subscriber? Click here to view full article